Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Encompass Health CorpEHC · Entity 3460 | Chief Accounting Officer | August 31, 2026 | September 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Encompass Health Corp
Report date August 31, 2026 · Filed September 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Encompass Health Common StockSEC Table I · non-derivative | Direct | 69,483 |
Reported balance
After 2026-08-31 transaction · row 1
1 source rowRow 1 · 2026-08-31 · Sale · Disposed 5,211 · Balance 69,483 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2018 Filed Feb 26, 2018 22:38 UTC | Encompass Health Corp EHC · Entity 3460 | GrantHealthsouth Common Stock | 5,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-008481 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,327 F1 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 18, 2016. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:15 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingHealthsouth Common Stock | 1,184 | $52.10 | $61,686.40 |
DisclosureSEC source: 0001127602-18-007540 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,870 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 20:31 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingHealthsouth Common Stock | 1,592 | $49.41 | $78,660.72 |
DisclosureSEC source: 0001127602-18-000516 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,054 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2017 Filed Feb 21, 2017 19:48 UTC | Encompass Health Corp HLS · Entity 3460 | Tax withholdingHealthsouth Common Stock | 829 | $42.00 | $34,818.00 |
DisclosureSEC source: 0001127602-17-007313 · form4.xml · nonDerivative · entry 3 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,646 F3 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 19:48 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 3,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007313 · form4.xml · nonDerivative · entry 2 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,475 F2 · shares: This grant of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 19, 2015. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 19:48 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 2,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007313 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,335 F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 19:51 UTC | Encompass Health Corp HLS · Entity 3460 | Tax withholdingHealthsouth Common Stock | 496 | $41.48 | $20,574.08 |
DisclosureSEC source: 0001127602-17-006244 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,523 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 14:45 UTC | Encompass Health Corp HLS · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.19 | $0.00 |
DisclosureSEC source: 0001127602-17-005131 · form4.xml · derivative · entry 3 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Healthsouth Common Stock · 15,000 shares Expires 2017-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 14:45 UTC | Encompass Health Corp HLS · Entity 3460 | Tax withholdingHealthsouth Common Stock | 11,571 | $40.38 | $467,279.79 |
DisclosureSEC source: 0001127602-17-005131 · form4.xml · nonDerivative · entry 2 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,019 F1 · shares: These shares were withheld or surrendered to pay the insider's option exercise price and tax withholding obligations incurred in connection with the exercise of the stock options being reported herein. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 14:45 UTC | Encompass Health Corp HLS · Entity 3460 | Exercise / conversionHealthsouth Common Stock | 15,000 | $23.19 | $347,850.00 |
DisclosureSEC source: 0001127602-17-005131 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:00 UTC | Encompass Health Corp HLS · Entity 3460 | Tax withholdingHealthsouth Common Stock | 1,635 | $41.24 | $67,427.40 |
DisclosureSEC source: 0001127602-17-000999 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,590 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.